International Union of Pharmacology. XXXV. The Glucagon Receptor Family

Peptide hormones within the secretin-glucagon family are expressed in endocrine cells of the pancreas and gastrointestinal epithelium and in specialized neurons in the brain, and subserve multiple biological functions, including regulation of growth, nutrient intake, and transit within the gut, and digestion, energy absorption, and energy assimilation. Glucagon, glucagon-like peptide-1, glucagon-like peptide-2, glucose-dependent insulinotropic peptide, growth hormone-releasing hormone and secretin are structurally related peptides that exert their actions through unique members of a structurally related G protein-coupled receptor class 2 family. This review discusses advances in our understanding of how these peptides exert their biological activities, with a focus on the biological actions and structural features of the cognate receptors. The receptors have been named after their parent and only physiologically relevant ligand, in line with the recommendations of the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR).

[1]  B. Göke,et al.  Molecular cloning of a cDNA encoding for the GLP-1 receptor expressed in rat lung. , 2009, Experimental and clinical endocrinology.

[2]  D. Singleton,et al.  Structure-function analysis of a series of glucagon-like peptide-1 analogs. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[3]  D. Drucker Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. , 2003, Molecular endocrinology.

[4]  P. Sexton,et al.  Novel Receptor Partners and Function of Receptor Activity-modifying Proteins* , 2003, The Journal of Biological Chemistry.

[5]  J. Holst,et al.  Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Yazhou Li,et al.  Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis* , 2003, The Journal of Biological Chemistry.

[7]  T. Lybrand,et al.  Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus. , 2002, Molecular endocrinology.

[8]  R. Pederson,et al.  Glucose-dependent Insulinotropic Polypeptide Activates the Raf-Mek1/2-ERK1/2 Module via a Cyclic AMP/cAMP-dependent Protein Kinase/Rap1-mediated Pathway* , 2002, The Journal of Biological Chemistry.

[9]  A. Schally,et al.  Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer. , 2002, The Journal of clinical endocrinology and metabolism.

[10]  L. Miller,et al.  Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. , 2002, Cancer research.

[11]  R. B. Merrifield,et al.  Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling. , 2002, Biochemistry.

[12]  M. Mattson,et al.  Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4 , 2002, Journal of Pharmacology and Experimental Therapeutics.

[13]  P. Light,et al.  Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism. , 2002, Molecular endocrinology.

[14]  A. Schally,et al.  The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Shull,et al.  An alternate pathway of cAMP-stimulated Cl secretion across the NKCC1-null murine duodenum. , 2002, Gastroenterology.

[16]  Chunling Zhang,et al.  Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Yusta,et al.  Glucagon-like Peptide-2 Receptor Activation Engages Bad and Glycogen Synthase Kinase-3 in a Protein Kinase A-dependent Manner and Prevents Apoptosis following Inhibition of Phosphatidylinositol 3-Kinase* , 2002, The Journal of Biological Chemistry.

[18]  C. Saper,et al.  Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. , 2002, The Journal of clinical investigation.

[19]  Yuichiro Yamada,et al.  Inhibition of gastric inhibitory polypeptide signaling prevents obesity , 2002, Nature Medicine.

[20]  J. Holst,et al.  Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats , 2002, Regulatory Peptides.

[21]  S. Dib,et al.  Role of the Gly40Ser Mutation in the Glucagon Receptor Gene in Brazilian Patients With Type 2 Diabetes Mellitus , 2002, Pancreas.

[22]  M. Matsubara,et al.  A composite hormone response element regulates transcription of the rat GHRH receptor gene. , 2002, Endocrinology.

[23]  J. Holst,et al.  Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study , 2002, The Lancet.

[24]  V. Hruby,et al.  Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells. , 2002, Diabetes.

[25]  P. Mullis,et al.  Decreased expression of the GHRH receptor gene due to a mutation in a Pit-1 binding site. , 2002, Molecular endocrinology.

[26]  N. Greig,et al.  A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. , 2002, The Journal of pharmacology and experimental therapeutics.

[27]  R. Pederson,et al.  Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats. , 2002, Diabetes.

[28]  J. Egan,et al.  The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. , 2002, The Journal of clinical endocrinology and metabolism.

[29]  A. Kuki,et al.  Human glucagon receptor antagonists based on alkylidene hydrazides. , 2002, Bioorganic & medicinal chemistry letters.

[30]  J. Livingston,et al.  Discovery of 5-hydroxyalkyl-4-phenylpyridines as a new class of glucagon receptor antagonists. , 2002, Bioorganic & medicinal chemistry letters.

[31]  P. Flatt,et al.  Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide. , 2002, Biochemical and biophysical research communications.

[32]  D. Bataille,et al.  Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology. , 2002, Diabetes.

[33]  L. Miller,et al.  Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma. , 2002, Gastroenterology.

[34]  J. Sturis,et al.  Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. , 2002, Diabetes.

[35]  R. Horikawa [Isolated GH deficiency due to inactivating mutation of GHRH receptor]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[36]  D. Drucker Biological actions and therapeutic potential of the glucagon-like peptides. , 2002, Gastroenterology.

[37]  M. Zdravkovic,et al.  The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men , 2002, Diabetologia.

[38]  J. Stock,et al.  Glycemic control in mice with targeted disruption of the glucagon receptor gene. , 2002, Biochemical and biophysical research communications.

[39]  J. Holst,et al.  The truncated metabolite GLP-2 (3–33) interacts with the GLP-2 receptor as a partial agonist , 2002, Regulatory Peptides.

[40]  O. Chepurny,et al.  Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic β-cell lines for use in transplantation , 2002, Cell and Tissue Research.

[41]  T. Shibasaki,et al.  Critical Role of cAMP-GEFII·Rim2 Complex in Incretin-potentiated Insulin Secretion* , 2001, The Journal of Biological Chemistry.

[42]  Anthony J Harmar,et al.  Family-B G-protein-coupled receptors , 2001, Genome Biology.

[43]  J. Holst,et al.  Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. , 2001, Diabetes.

[44]  K. Petersen,et al.  Effects of a novel glucagon receptor antagonist (Bay 27–9955) on glucagon-stimulated glucose production in humans , 2001, Diabetologia.

[45]  M. Beinborn,et al.  A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain. , 2001, The Journal of biological chemistry.

[46]  O. Chepurny,et al.  cAMP‐regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+‐induced Ca2+ release in INS‐1 pancreatic β‐cells , 2001, The Journal of physiology.

[47]  D. Smith,et al.  Oxyntomodulin inhibits food intake in the rat. , 2001, Endocrinology.

[48]  M. Bjerknes,et al.  Modulation of specific intestinal epithelial progenitors by enteric neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Holst,et al.  Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. , 2001, Diabetes care.

[50]  D. Hörsch,et al.  Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. , 2001, Molecular endocrinology.

[51]  A. Astrup,et al.  A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[52]  D. Drucker Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes. , 2001, Current pharmaceutical design.

[53]  A. Kuki,et al.  Identification of alkylidene hydrazides as glucagon receptor antagonists. , 2001, Journal of medicinal chemistry.

[54]  J. Jameson,et al.  Absence of constitutively activating mutations in the GHRH receptor in GH-producing pituitary tumors. , 2001, The Journal of clinical endocrinology and metabolism.

[55]  R. Pederson,et al.  A New Pathway for Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor Signaling , 2001, The Journal of Biological Chemistry.

[56]  B. Yusta,et al.  Glucagon-like Peptide (GLP)-2 Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor Signaling* , 2001, The Journal of Biological Chemistry.

[57]  M. Thorner,et al.  Molecular cloning of ovine and bovine growth hormone-releasing hormone receptors: the ovine receptor is C-terminally truncated. , 2001, Endocrinology.

[58]  R. Pederson,et al.  Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP). , 2001, Biochimica et biophysica acta.

[59]  R. Pederson,et al.  Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats. , 2001, Diabetes.

[60]  T. G. Burns,et al.  A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. , 2001, The Journal of pediatrics.

[61]  D. Irwin Molecular evolution of proglucagon , 2001, Regulatory Peptides.

[62]  M. Schwartz,et al.  GLP-2α accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion , 2001 .

[63]  A. Korytko,et al.  Differential GH-releasing hormone regulation of GHRH receptor mRNA expression in the rat pituitary. , 2001, American journal of physiology. Endocrinology and metabolism.

[64]  C. Östenson,et al.  Different domains in the third intracellular loop of the GLP-1 receptor are responsible for Gαs and Gαi/Gαo activation , 2001 .

[65]  J. Holst,et al.  Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. , 2001, Gastroenterology.

[66]  D. Irwin,et al.  Evolution of receptors for proglucagon-derived peptides: isolation of frog glucagon receptors. , 2001, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[67]  J. Holst,et al.  Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. , 2001, Diabetes.

[68]  B. Harding,et al.  Absence of mutations in the growth hormone (GH)‐releasing hormone receptor gene in GH‐secreting pituitary adenomas , 2001, Clinical endocrinology.

[69]  R. Kineman,et al.  The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback. , 2001, Endocrinology.

[70]  H. Hassan Biological activities of two porcine growth hormone-releasing hormone receptor isoforms. , 2001, Archives of biochemistry and biophysics.

[71]  M. Wheeler,et al.  Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo. , 2001, Biochemistry.

[72]  D. Drucker,et al.  Minireview: the glucagon-like peptides. , 2001, Endocrinology.

[73]  C. Foged,et al.  The growth hormone-releasing hormone receptor: desensitisation following short-term agonist exposure. , 2001, Acta Pharmacologica et Toxicologica.

[74]  P. Godfrey,et al.  Regulation of the pituitary somatotroph cell by GHRH and its receptor. , 2000, Recent progress in hormone research.

[75]  M. Wheeler,et al.  Characterization of glucagon-like peptide-1 receptor-binding determinants. , 2000, Journal of molecular endocrinology.

[76]  L. Miller,et al.  Dual Contacts between Peptide Agonist Ligands and the Secretin Receptor Directly Established by Photoaffinity Labeling , 2000, Annals of the New York Academy of Sciences.

[77]  B. Yusta,et al.  The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent Pathway* , 2000, The Journal of Biological Chemistry.

[78]  Y. Asmann,et al.  Structural insights into the amino-terminus of the secretin receptor: I. Status of cysteine and cystine residues. , 2000, Molecular pharmacology.

[79]  L. Miller,et al.  Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation. , 2000, The Journal of pharmacology and experimental therapeutics.

[80]  Yasuhiro Sunaga,et al.  cAMP-GEFII is a direct target of cAMP in regulated exocytosis , 2000, Nature Cell Biology.

[81]  J. Holst,et al.  Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. , 2000, Endocrinology.

[82]  B. Yusta,et al.  Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine. , 2000, Endocrinology.

[83]  J. Holst,et al.  Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: Distribution and binding of I.V. injected 125-I-GLP-2 , 2000, Regulatory Peptides.

[84]  H. Vaudry,et al.  Molecular evolution of the growth hormone-releasing hormone/pituitary adenylate cyclase-activating polypeptide gene family. Functional implication in the regulation of growth hormone secretion. , 2000, Journal of molecular endocrinology.

[85]  J. Holst,et al.  Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected 125I-GLP-2 , 2000, Peptides.

[86]  A. Schally,et al.  Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[87]  B. Yusta,et al.  Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. , 2000, Gastroenterology.

[88]  B Perkins,et al.  Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. , 2000, Diabetes.

[89]  D. Dransfield,et al.  Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells , 2000, Peptides.

[90]  B. Yusta,et al.  Structural determinants for activity of glucagon-like peptide-2. , 2000, Biochemistry.

[91]  D. Moller,et al.  New approaches in the treatment of type 2 diabetes. , 2000, Current opinion in chemical biology.

[92]  D. Pipeleers,et al.  Glucagon receptors on human islet cells contribute to glucose competence of insulin release , 2000, Diabetologia.

[93]  J. Holst,et al.  In vivo and in vitro degradation of glucagon-like peptide-2 in humans. , 2000, The Journal of clinical endocrinology and metabolism.

[94]  R. B. Merrifield,et al.  Selective Stabilization of the High Affinity Binding Conformation of Glucagon Receptor by the Long Splice Variant of Gαs * , 2000, The Journal of Biological Chemistry.

[95]  P. J. Larsen,et al.  The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake , 2000, Nature Medicine.

[96]  W. Chance,et al.  Maintaining Gut Integrity During Parenteral Nutrition of Tumor-Bearing Rats: Effects of Glucagon-Like Peptide 2 , 2000, Nutrition and cancer.

[97]  P. Yang,et al.  Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse , 2000, Gut.

[98]  H. Vaudry,et al.  Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. , 2000, Pharmacological reviews.

[99]  P. Flatt,et al.  Improved glycaemic control in obese diabetic ob/ob mice using N-terminally modified gastric inhibitory polypeptide. , 2000, The Journal of endocrinology.

[100]  J. Palazzo,et al.  Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2. , 2000, Journal of pediatric surgery.

[101]  S. Bonner-Weir,et al.  Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. , 2000, Diabetes.

[102]  D. Drucker,et al.  Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[103]  H. Rasmussen,et al.  Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. , 2000, Endocrinology.

[104]  M. Schwartz,et al.  Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion. , 2000, Journal of pediatric surgery.

[105]  S. Woods,et al.  Targeted gene disruption in endocrine research--the case of glucagon-like peptide-1 and neuroendocrine function. , 2000, Endocrinology.

[106]  D. Drucker,et al.  Neuroendocrine Function and Response to Stress in Mice with Complete Disruption of Glucagon-Like Peptide-1 Receptor Signaling1. , 2000, Endocrinology.

[107]  R. Kineman Antitumorigenic actions of growth hormone-releasing hormone antagonists. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[108]  J. Miyazaki,et al.  Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[109]  M. Wolfe,et al.  GIP biology and fat metabolism. , 1999, Life sciences.

[110]  J. Habener,et al.  The glucagon-like peptides. , 1999, Endocrine reviews.

[111]  A. Schally,et al.  Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents , 1999, Trends in Endocrinology & Metabolism.

[112]  B. Yusta,et al.  Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. , 1999, American journal of physiology. Endocrinology and metabolism.

[113]  L. Josefsson,et al.  Evidence for kinship between diverse G-protein coupled receptors. , 1999, Gene.

[114]  E. Blázquez,et al.  Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. , 1999, American journal of physiology. Endocrinology and metabolism.

[115]  S. Grinstein,et al.  Identification of Glucagon-like Peptide-2 (GLP-2)-activated Signaling Pathways in Baby Hamster Kidney Fibroblasts Expressing the Rat GLP-2 Receptor* , 1999, The Journal of Biological Chemistry.

[116]  S. Mojsov,et al.  Functional studies of a glucagon receptor isolated from frog Rana tigrina rugulosa: implications on the molecular evolution of glucagon receptors in vertebrates , 1999, FEBS letters.

[117]  P. Godfrey,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Rat Growth Hormone-Releasing Hormone Receptor Gene: Structure, Regulation, and Generation of Receptor Isoforms with Different Signaling Properties* , 1999 .

[118]  H. Bode,et al.  Glucagon-Like Peptide 1 Elevates Cytosolic Calcium in Pancreaticβ -Cells Independently of Protein Kinase A1. , 1999, Endocrinology.

[119]  B. Yusta,et al.  Biologic properties and therapeutic potential of glucagon-like peptide-2. , 1999, JPEN. Journal of parenteral and enteral nutrition.

[120]  R. Pederson,et al.  Characterization of the Carboxyl-terminal Domain of the Rat Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor , 1999, The Journal of Biological Chemistry.

[121]  G. Morel,et al.  Restricted Presence of the Growth Hormone-Releasing Hormone Receptor to Somatotropes in Rat and Human Pituitaries , 1999, Neuroendocrinology.

[122]  I. De Meester,et al.  CD26, let it cut or cut it down. , 1999, Immunology today.

[123]  C. Cotton,et al.  The human secretin receptor gene: genomic organization and promoter characterization , 1999, FEBS letters.

[124]  L. Miller,et al.  Identification of an Interaction between Residue 6 of the Natural Peptide Ligand and a Distinct Residue within the Amino-terminal Tail of the Secretin Receptor* , 1999, The Journal of Biological Chemistry.

[125]  T. Sakmar,et al.  Two Cytoplasmic Loops of the Glucagon Receptor Are Required to Elevate cAMP or Intracellular Calcium* , 1999, The Journal of Biological Chemistry.

[126]  D. Drucker,et al.  Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. , 1999, Gastroenterology.

[127]  C. Tortorella,et al.  Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway , 1999, Peptides.

[128]  P. Gaudreau,et al.  Differential in Vivo Regulation of the Pituitary Growth Hormone-Releasing Hormone (GHRH) Receptor by GHRH in Young and Aged Rats. , 1999, Endocrinology.

[129]  S. Germain,et al.  Encapsulated, Genetically Engineered Cells, Secreting Glucagon‐like Peptide‐1 for the Treatment of Non‐insulin‐dependent Diabetes Mellitus , 1999, Annals of the New York Academy of Sciences.

[130]  J. Habener,et al.  cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). , 1999, The Journal of biological chemistry.

[131]  D. Drucker Glucagon-like Peptide 2 , 1999, Trends in Endocrinology & Metabolism.

[132]  P. MacDonald,et al.  Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. , 1999, Diabetes.

[133]  C. Beglinger,et al.  rapid communication Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2 , 2022 .

[134]  K. Chihara,et al.  Cloning and Characterization of the 5′-Flanking Region of the Human Growth Hormone-releasing Hormone Receptor Gene* , 1999, The Journal of Biological Chemistry.

[135]  F. Ashcroft,et al.  Miniglucagon (Glucagon 19–29), a Potent and Efficient Inhibitor of Secretagogue-induced Insulin Release through a Ca2+Pathway* , 1999, The Journal of Biological Chemistry.

[136]  P. Flatt,et al.  NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity. , 1999, Diabetes.

[137]  B. Gaylinn Molecular and cell biology ofthe growth hormone-releasing hormone receptor , 1999 .

[138]  B. Gaylinn Molecular and cell biology of the growth hormone-releasing hormone receptor. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[139]  F. Gracia‐Navarro,et al.  Growth Hormone (GH)-Releasing Factor Differentially Activates Cyclic Adenosine 3',5'-Monophosphate- and Inositol Phosphate-Dependent Pathways to Stimulate GH Release in Two Porcine Somatotrope Subpopulations. , 1999, Endocrinology.

[140]  M. Svoboda,et al.  Identification of a Glucose Response Element in the Promoter of the Rat Glucagon Receptor Gene* , 1999, The Journal of Biological Chemistry.

[141]  M. Levine,et al.  Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. , 1999, The Journal of clinical endocrinology and metabolism.

[142]  D. Drucker,et al.  Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[143]  J. Schrezenmeir,et al.  Biological activity of GLP-1-analogues with N-terminal modifications , 1999, Regulatory Peptides.

[144]  H. Trusheim,et al.  Gene Expression of the Human Glucagon-Like Peptide-1 Receptor Is Regulated by Sp1 and Sp3. , 1999, Endocrinology.

[145]  M. Wolfe,et al.  Structure of the rat glucose-dependent insulinotropic polypeptide receptor gene , 1999, Peptides.

[146]  R. Burcelin,et al.  Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1. , 1999, Metabolism: clinical and experimental.

[147]  A. Schally,et al.  Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[148]  P. Shughrue,et al.  Distribution of pre‐pro‐glucagon and glucagon‐like peptide‐1 receptor messenger RNAs in the rat central nervous system , 1999, The Journal of comparative neurology.

[149]  L. Miller,et al.  Demonstration of a Direct Interaction between Residue 22 in the Carboxyl-terminal Half of Secretin and the Amino-terminal Tail of the Secretin Receptor Using Photoaffinity Labeling* , 1999, The Journal of Biological Chemistry.

[150]  P. Stevens,et al.  Functional GHRH receptor carboxyl terminal isoforms in normal and dwarf (dw) rats. , 1998, Journal of molecular endocrinology.

[151]  R. Carr,et al.  Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists. , 1998, Journal of medicinal chemistry.

[152]  W. MacNaughton,et al.  GLP-2 augments the adaptive response to massive intestinal resection in rat. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[153]  B. Göke,et al.  Contribution of a PS1‐like element to the tissue‐ and cell‐specific expression of the human GLP‐1 receptor gene , 1998, FEBS letters.

[154]  G. Ramadori,et al.  A synthetic glucagon-like peptide-1 analog with improved plasma stability. , 1998, The Journal of endocrinology.

[155]  J. Blanco,et al.  Dipeptidyl‐peptidase IV‐β , 1998 .

[156]  T. Kishimoto,et al.  Inhibition of signal transduction by a splice variant of the growth hormone-releasing hormone receptor expressed in human pituitary adenomas. , 1998, Metabolism: clinical and experimental.

[157]  C. Delporte,et al.  Molecular cloning and in vitro properties of the recombinant rabbit secretin receptor , 1998, Peptides.

[158]  J. Dunphy,et al.  Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression 1 This work was supported by a grant from the Crohn's and Colitis Foundation of America. 1 , 1998, Molecular and Cellular Endocrinology.

[159]  J. Gromada,et al.  Glucagon-mediated Ca2+signaling in BHK cells expressing cloned human glucagon receptors. , 1998, American journal of physiology. Cell physiology.

[160]  K. Mayo,et al.  Identification of binding domains of the growth hormone-releasing hormone receptor by analysis of mutant and chimeric receptor proteins. , 1998, Molecular endocrinology.

[161]  C. Tseng,et al.  The cysteine of the cytoplasmic tail of glucose-dependent insulinotropic peptide receptor mediates its chronic desensitization and down-regulation , 1998, Molecular and Cellular Endocrinology.

[162]  B. Göke,et al.  Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. , 1998, The Journal of clinical investigation.

[163]  T. Hansen,et al.  Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells , 1998, Diabetologia.

[164]  M. Caron,et al.  A Role for Receptor Kinases in the Regulation of Class II G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[165]  L. Miller,et al.  Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. , 1998, Gastroenterology.

[166]  H. Schulte,et al.  Structure and regulation of the human growth hormone-releasing hormone receptor gene. , 1998, Molecular endocrinology.

[167]  S. Amselem,et al.  Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. , 1998, The Journal of clinical endocrinology and metabolism.

[168]  J. Holst,et al.  Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity , 1998, Diabetologia.

[169]  D. Drucker Glucagon-Like Peptides , 1998, Diabetes.

[170]  C. Donaldson,et al.  Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies. , 1998, Journal of medicinal chemistry.

[171]  B. Göke,et al.  Five Out of Six Tryptophan Residues in the N-Terminal Extracellular Domain of the Rat GLP-1 Receptor Are Essential for its Ability to Bind GLP-1 , 1997, Peptides.

[172]  M. Tota,et al.  Fluorescein-Trp25-Exendin-4, a Biologically Active Fluorescent Probe for the Human GLP-1 Receptor , 1997, Peptides.

[173]  B. Göke,et al.  Cloning and Characterization of the 5′ Flanking Sequences (Promoter Region) of the Human GLP-1 Receptor Gene , 1997, Peptides.

[174]  D. Drucker,et al.  Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[175]  J. Takahara,et al.  Gene regulation of growth hormone-releasing hormone and its receptor. , 1997, Endocrine journal.

[176]  H. Maheshwari,et al.  The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH‐releasing hormone receptor gene , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[177]  Yihong Wang,et al.  Novel signal transduction and peptide specificity of glucagon‐like peptide receptor in 3T3‐L1 adipocytes , 1997, Journal of cellular physiology.

[178]  J. Livingston,et al.  Role of the Glucagon Receptor COOH-Terminal Domain in Glucagon-Mediated Signaling and Receptor Internalization , 1997, Diabetes.

[179]  W. Chance,et al.  Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2. , 1997, The American journal of physiology.

[180]  C. Widmann,et al.  Internalization and homologous desensitization of the GLP-1 receptor depend on phosphorylation of the receptor carboxyl tail at the same three sites. , 1997, Molecular endocrinology.

[181]  D. Drucker,et al.  Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. , 1997, The American journal of physiology.

[182]  D. Drucker,et al.  Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV , 1997, Nature Biotechnology.

[183]  J. Holst,et al.  The pathogenesis of NIDDM involves a defective expression of the GIP receptor , 1997, Diabetologia.

[184]  Y. Seino,et al.  Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and -insensitive pathways. , 1997, Biochemical and biophysical research communications.

[185]  K. Mayo,et al.  Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. , 1997, Endocrinology.

[186]  R. Pederson,et al.  Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor. , 1997, Endocrinology.

[187]  D. Drucker,et al.  Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. , 1997, The American journal of physiology.

[188]  J. Habener,et al.  Insulinotropic Glucagon-Like Peptide I Receptor Expression in Glucagon-Producing α-Cells of the Rat Endocrine Pancreas , 1997, Diabetes.

[189]  R. Pederson,et al.  GIP6–30amide contains the high affinity binding region of GIP and is a potent inhibitor of GIP1–42action in vitro , 1997, Regulatory Peptides.

[190]  L. Lin,et al.  A point mutation in the glucose-dependent insulinotropic peptide receptor confers constitutive activity. , 1997, Biochemical and biophysical research communications.

[191]  D. Drucker,et al.  Biological determinants of intestinotrophic properties of GLP-2 in vivo. , 1997, The American journal of physiology.

[192]  R. Kineman,et al.  Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels. , 1997, Endocrinology.

[193]  T. Ogihara,et al.  Tissue-Specific and Glucose-Dependent Expression of Receptor Genes for Glucagon and Glucagon-Like Peptide-1 (GLP-1) , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[194]  A. Korytko,et al.  Thyroid hormone and glucocorticoid regulation of pituitary growth hormone-releasing hormone receptor gene expression. , 1997, The Journal of endocrinology.

[195]  P. J. Larsen,et al.  Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem , 1997, Neuroscience.

[196]  J. Fuselier,et al.  Structural Simplification of Potent Growth Hormone‐Releasing Hormone Analogs: Implications for Other Members of the VIP/GHRH/PACAP Family a , 1996, Annals of the New York Academy of Sciences.

[197]  S. Chambers,et al.  HYPOTHESIS: GLUCAGON RECEPTOR GLYCINE TO SERINE MISSENSE MUTATION CONTRIBUTES TO ONE IN 20 CASES OF ESSENTIAL HYPERTENSION * , 1996, Clinical and experimental pharmacology & physiology.

[198]  T. Usdin,et al.  Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. , 1996, The Journal of clinical investigation.

[199]  P. Godfrey,et al.  The Growth‐Hormone‐Releasing Hormone Receptor: Signal Transduction, Gene Expression, and Physiological Function in Growth Regulation a , 1996, Annals of the New York Academy of Sciences.

[200]  K. Tsuda,et al.  Identification of Two Missense Mutations in the GIP Receptor Gene: A Functional Study and Association Analysis with NIDDM: No Evidence of Association with Japanese NIDDM Subjects , 1996, Diabetes.

[201]  J. Christophe,et al.  Glucagon and Its Receptor in Various Tissues , 1996, Annals of the New York Academy of Sciences.

[202]  I. Merchenthaler,et al.  Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. , 1996, Endocrinology.

[203]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[204]  D. Smith,et al.  Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on alpha-TSH cells. , 1996, Endocrinology.

[205]  M. Byrne,et al.  Human Studies with Glucagon‐like‐peptide‐1: Potential of the Gut Hormone for Clinical Use , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[206]  L. Miller,et al.  Role of Receptor Phosphorylation in Desensitization and Internalization of the Secretin Receptor* , 1996, The Journal of Biological Chemistry.

[207]  R. Pederson,et al.  Investigation of Glucose-dependent Insulinotropic Polypeptide(1-42) and Glucagon-like Peptide-1-(7-36) Degradation in Vitro by Dipeptidyl Peptidase IV Using Matrix-assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry , 1996, The Journal of Biological Chemistry.

[208]  C. Cheeseman,et al.  The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport. , 1996, The American journal of physiology.

[209]  H. Bonjer,et al.  Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. , 1996, The Journal of clinical endocrinology and metabolism.

[210]  D. Drucker,et al.  Induction of intestinal epithelial proliferation by glucagon-like peptide 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[211]  N. Miki,et al.  Regulation of pituitary growth hormone-releasing factor (GRF) receptor gene expression by GRF. , 1996, Biochemical and Biophysical Research Communications - BBRC.

[212]  Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP): Effect of a GIP-specific receptor antagonist , 1996, Regulatory Peptides.

[213]  J. Habener,et al.  Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. , 1996, Endocrinology.

[214]  L. Miller,et al.  Multiple Extracellular Loop Domains Contribute Critical Determinants for Agonist Binding and Activation of the Secretin Receptor* , 1996, The Journal of Biological Chemistry.

[215]  K. Lam,et al.  Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen. , 1996, Neuroendocrinology.

[216]  A. Torsello,et al.  Growth hormone-releasing factor (GRF) regulates expression of its own receptor. , 1996, Endocrinology.

[217]  O. Pescovitz,et al.  A novel peptide from the growth hormone releasing hormone gene stimulates Sertoli cell activity. , 1996, Endocrinology.

[218]  A. Korytko,et al.  Developmental regulation of pituitary growth hormone-releasing hormone receptor gene expression in the rat. , 1996, Endocrinology.

[219]  D. Pipeleers,et al.  Expression and Functional Activity of Glucagon, Glucagon-Like Peptide I, and Glucose-Dependent Insulinotropic Peptide Receptors in Rat Pancreatic Islet Cells , 1996, Diabetes.

[220]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[221]  H. Hsiung,et al.  Characterization of growth hormone-releasing hormone (GHRH) binding to cloned porcine GHRH receptor , 1995, Peptides.

[222]  B. Göke,et al.  Characterization of GIP(1–30) and GIP(1–42) as stimulators of proinsulin gene transcription , 1995, Peptides.

[223]  N. Miki,et al.  Thyroid hormone regulation of gene expression of the pituitary growth hormone-releasing factor receptor. , 1995, Biochemical and biophysical research communications.

[224]  N. Miki,et al.  Sexually dimorphic expression of pituitary growth hormone-releasing factor receptor in the rat. , 1995, Biochemical and biophysical research communications.

[225]  R. B. Merrifield,et al.  Characterization of Deletion and Truncation Mutants of the Rat Glucagon Receptor , 1995, The Journal of Biological Chemistry.

[226]  L. Miller,et al.  Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor. , 1995, Molecular pharmacology.

[227]  P. J. Larsen,et al.  Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites , 1995, The European journal of neuroscience.

[228]  R. Burcelin,et al.  Cloning and sequence analysis of the murine glucagon receptor-encoding gene. , 1995, Gene.

[229]  B. Chow,et al.  Localization of the gene encoding the secretin receptor, SCTR, on human chromosome 2q14.1 by fluorescence in situ hybridization and chromosome morphometry. , 1995, Genomics.

[230]  P. Froguel,et al.  Cloning, Functional Expression, and Chromosomal Localization of the Human Pancreatic Islet Glucose-Dependent Insulinotropic Polypeptide Receptor , 1995, Diabetes.

[231]  Y. Shigeyoshi,et al.  Regional distribution of growth hormone-releasing hormone (GHRH) receptor mRNA in the rat brain. , 1995, Endocrinology.

[232]  Y. Seino,et al.  Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA. , 1995, Genomics.

[233]  J. Brown,et al.  Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. , 1995, Endocrinology.

[234]  T. Ohnishi,et al.  Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas. , 1995, The Journal of clinical endocrinology and metabolism.

[235]  J. Takahara,et al.  Differential gene expression of growth hormone (GH)-releasing hormone (GRH) and GRH receptor in various rat tissues. , 1995, Endocrinology.

[236]  R. Bretzel,et al.  The Effects of Glucagon‐like Peptide‐I (GLP‐I) on Hormone Secretion from Isolated Human Pancreatic Islets , 1995, Pancreas.

[237]  R. Collu,et al.  Identification of human growth hormone-releasing hormone receptor splicing variants. , 1995, The Journal of clinical endocrinology and metabolism.

[238]  R. Pederson,et al.  Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. , 1995, Endocrinology.

[239]  J. Habener,et al.  Activation of a cAMP-regulated Ca-Signaling Pathway in Pancreatic -Cells by the Insulinotropic Hormone Glucagon-like Peptide-1 (*) , 1995, The Journal of Biological Chemistry.

[240]  B. Chow Molecular cloning and functional characterization of a human secretin receptor. , 1995, Biochemical and biophysical research communications.

[241]  E. Nishimura,et al.  Regulation of Glucagon Receptor mRNA in Cultured Primary Rat Hepatocytes by Glucose and cAMP (*) , 1995, The Journal of Biological Chemistry.

[242]  J. Vilardaga,et al.  Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. , 1995, Biochemical and biophysical research communications.

[243]  L. Miller,et al.  Critical Contributions of Amino-terminal Extracellular Domains in Agonist Binding and Activation of Secretin and Vasoactive Intestinal Polypeptide Receptors. STUDIES OF CHIMERIC RECEPTORS (*) , 1995, The Journal of Biological Chemistry.

[244]  B. Göke,et al.  Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. , 1995, Endocrine reviews.

[245]  E. Nishimura,et al.  Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids. , 1995, Endocrinology.

[246]  S. Ohashi,et al.  Evidence that glucagon stimulates insulin secretion through its own receptor in rats , 1995, Diabetologia.

[247]  G. Velho,et al.  A missense mutation in the glucagon receptor gene is associated with non–insulin–dependent diabetes mellitus , 1995, Nature Genetics.

[248]  S. Mojsov,et al.  Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences , 1995, FEBS letters.

[249]  B. Göke,et al.  Reduction of the Incretin Effect in Rats by the Glucagon-Like Peptide 1 Receptor Antagonist Exendin (9–39) Amide , 1995, Diabetes.

[250]  B. Göke,et al.  Glycosylation of the GLP-1 receptor is a prerequisite for regular receptor function , 1994, Peptides.

[251]  S. Seino,et al.  Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells: its structure and functional properties. , 1994, Biochemical and biophysical research communications.

[252]  A. Schally,et al.  Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[253]  H. Kim,et al.  Synthesis and expression of a gene for the rat glucagon receptor. Replacement of an aspartic acid in the extracellular domain prevents glucagon binding. , 1994, The Journal of biological chemistry.

[254]  P. Robberecht,et al.  Relative quantitative analysis of glucagon receptor mRNA in rat tissues , 1994, Molecular and Cellular Endocrinology.

[255]  S. Chua,et al.  Human growth hormone-releasing hormone receptor (GHRHR) maps to a YAC at Chromosome 7p15 , 1994, Mammalian Genome.

[256]  J. Holst,et al.  Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding. , 1994, The American journal of physiology.

[257]  M. Thorner,et al.  Photoaffinity cross-linking to the pituitary receptor for growth hormone-releasing factor. , 1994, Endocrinology.

[258]  J. Vincent,et al.  Ion channels and the signal transduction pathways in the regulation of growth hormone secretion , 1994, Trends in Endocrinology & Metabolism.

[259]  B. Göke,et al.  Signal transduction of the GLP‐1‐receptor cloned from a human insulinoma , 1994, FEBS letters.

[260]  F. Grant,et al.  The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization. , 1994, Gene.

[261]  M. Stoffel,et al.  Localization of the glucagon receptor gene to human chromosome band 17q25. , 1994, Genomics.

[262]  R. B. Merrifield,et al.  Identification of an essential serine residue in glucagon: implication for an active site triad. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[263]  C. Strader,et al.  Cloning and expression of a human glucagon receptor. , 1994, Biochemical and biophysical research communications.

[264]  M. Brownstein,et al.  Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. , 1993, Endocrinology.

[265]  L. Miller,et al.  Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors. , 1993, Gastroenterology.

[266]  Shaoping Deng,et al.  Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor , 1993, Diabetes.

[267]  C. Strader,et al.  Cloning and functional expression of a human glucagon-like peptide-1 receptor. , 1993, Biochemical and biophysical research communications.

[268]  M. Nakata,et al.  Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity. , 1993, Endocrinology.

[269]  M. Permutt,et al.  Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor. , 1993, Endocrinology.

[270]  B. Göke,et al.  Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. , 1993, The Journal of biological chemistry.

[271]  M. Stoffel,et al.  Human Glucagon-Like Peptide-1 Receptor Gene: Localization to Chromosome Band 6p21 by Fluorescence In Situ Hybridization and Linkage of a Highly Polymorphic Simple Tandem Repeat DNA Polymorphism to Other Markers on Chromosome 6 , 1993, Diabetes.

[272]  Aldons J. Lusis,et al.  Molecular basis of the little mouse phenotype and Implications for cell type-specific growth , 1993, Nature.

[273]  Nancy A. Jenkins,et al.  GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function , 1993, Nature Genetics.

[274]  H. Hsiung,et al.  Structure and functional expression of a complementary DNA for porcine growth hormone-releasing hormone receptor , 1993, Neuropeptides.

[275]  S. Shenolikar,et al.  Control of cholecystokinin receptor dephosphorylation in pancreatic acinar cells. , 1993, The Journal of biological chemistry.

[276]  B. Gallwitz,et al.  Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. , 1993, European journal of biochemistry.

[277]  J. Holst,et al.  Biological Effects and Metabolic Rates of Glucagonlike Peptide-1 7–36 Amide and Glucagonlike Peptide-1 7–37 in Healthy Subjects Are Indistinguishable , 1993, Diabetes.

[278]  P. Robberecht,et al.  A cDNA construct allowing the expression of rat hepatic glucagon receptors. , 1993, Biochemical and biophysical research communications.

[279]  F J Grant,et al.  Expression cloning and signaling properties of the rat glucagon receptor. , 1993, Science.

[280]  M. Wolfe,et al.  Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[281]  R. B. Merrifield,et al.  The role of histidine-1 in glucagon action. , 1993, Archives of biochemistry and biophysics.

[282]  M. Rosenfeld,et al.  Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth , 1992, Nature.

[283]  M. Dufau,et al.  Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function. , 1992, Endocrinology.

[284]  R. Campbell,et al.  Evolution of the growth hormone-releasing factor (GRF) family of peptides. , 1992, Growth regulation.

[285]  K. Mayo Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. , 1992, Molecular endocrinology.

[286]  P. Leymarie,et al.  Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. , 1992, The New England journal of medicine.

[287]  B. Thorens Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[288]  B. Göke,et al.  Solubilization of active GLP‐1 (7–36)amide receptors from RINm5F plasma membranes , 1992, FEBS letters.

[289]  A. S. French,et al.  FIVE pS ANION CHANNELS IN HUMAN AIRWAY EPITHELIAL CELLS , 1992 .

[290]  K. Catt,et al.  Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary. , 1992, Endocrinology.

[291]  Y. Kaziro,et al.  Molecular cloning and expression of a cDNA encoding the secretin receptor. , 1991, The EMBO journal.

[292]  A. Leiter,et al.  The secretin gene: evolutionary history, alternative splicing, and developmental regulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[293]  R. Knight,et al.  Production of a growth hormone-releasing hormone-like peptide and its mRNA by human lymphocytes. , 1991, Neuroendocrinology.

[294]  R. Campbell,et al.  GRF analogs and fragments: Correlation between receptor binding, activity and structure , 1991, Peptides.

[295]  B. Göke,et al.  Characterization of glucagon‐like peptide‐I(7–36)amide receptors of rat lung membranes by covalent cross‐linking , 1991, FEBS letters.

[296]  J. Habener,et al.  Functional receptors for the insulinotropic hormone glucagon‐like peptide‐I(7–37) on a somatostatin secreting cell line , 1991, FEBS letters.

[297]  R. B. Merrifield,et al.  Position 9 replacement analogs of glucagon uncouple biological activity and receptor binding. , 1991, The Journal of biological chemistry.

[298]  R. Jensen,et al.  Reduced peptide bond pseudopeptide analogues of secretin. A new class of secretin receptor antagonists. , 1991, The Journal of biological chemistry.

[299]  T. Abribat,et al.  Characterization of [125I-Tyr10]human growth hormone-releasing factor(1–44) amide binding to rat pituitary: evidence for high and low affinity classes of sites , 1990, Brain Research.

[300]  J. Kraicer,et al.  Effect of growth hormone-releasing factor on phosphoinositide hydrolysis in somatotrophs , 1990, Molecular and Cellular Endocrinology.

[301]  B. Göke,et al.  Characterization of receptors for glucagon‐like peptide‐1(7–36) amide on rat lung membranes , 1990, FEBS letters.

[302]  D. Bataille,et al.  Glucagon-(19-29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteins. , 1990, The Journal of biological chemistry.

[303]  E. Blázquez,et al.  Characterization of high‐affinity receptors for truncated glucagon‐like peptide‐1 in rat gastric glands , 1990, FEBS letters.

[304]  A. Leiter,et al.  Secretin: structure of the precursor and tissue distribution of the mRNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[305]  S. Asa,et al.  Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation. , 1989, Endocrinology.

[306]  S. Suhr,et al.  Mouse growth-hormone-releasing hormone: precursor structure and expression in brain and placenta. , 1989, Molecular endocrinology.

[307]  P. Chomczyński,et al.  Cloning and characterization of mouse growth hormone-releasing hormone (GRH) complementary DNA: increased GRH messenger RNA levels in the growth hormone-deficient lit/lit mouse. , 1989, Molecular endocrinology.

[308]  B. Göke,et al.  Signal transmission after GLP-1(7-36)amide binding in RINm5F cells. , 1989, The American journal of physiology.

[309]  S. Kadowaki,et al.  Mechanism for increase of gastrin release by secretin in Zollinger-Ellison syndrome. , 1989, Gastroenterology.

[310]  L. Frohman,et al.  Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. , 1989, The Journal of clinical investigation.

[311]  J. Conlon,et al.  Characterization of the receptor for glucagon-like peptide-1(7-36)amide on plasma membranes from rat insulinoma-derived cells by covalent cross-linking. , 1989, Journal of molecular endocrinology.

[312]  D. Drucker,et al.  Glucagon gene expression in vertebrate brain. , 1988, The Journal of biological chemistry.

[313]  J. Holst,et al.  Effect of truncated glucagon‐like peptide 1 on cAMP in rat gastric glands and HGT‐1 human gastric cancer cells , 1988, FEBS letters.

[314]  R. Hammer,et al.  Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. , 1988, Molecular endocrinology.

[315]  O. Pescovitz,et al.  Identification of a rat GHRH-like substance and its messenger RNA in rat testis. , 1988, Endocrinology.

[316]  J. Holst,et al.  Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine. , 1988, The Journal of biological chemistry.

[317]  M. Thorner,et al.  Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effects of growth hormone-releasing factor and somatostatin. , 1988, Endocrinology.

[318]  J. Lauder,et al.  Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical study , 1988, The Journal of comparative neurology.

[319]  J. Conlon,et al.  Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells. , 1988, The Journal of endocrinology.

[320]  K. Shima,et al.  Identification and localization of glucagon-like peptide-1 and its receptor in rat brain. , 1987, Endocrinology.

[321]  R. Bruzzone,et al.  Secretin stimulates cyclic AMP and inositol trisphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[322]  D. Drucker,et al.  Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[323]  D. Bataille,et al.  A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon , 1987, Nature.

[324]  J. Holst,et al.  Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. , 1986, Endocrinology.

[325]  L. Orci,et al.  Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. , 1986, The Journal of biological chemistry.

[326]  V. Hruby,et al.  Activation of two signal-transduction systems in hepatocytes by glucagon , 1986, Nature.

[327]  L. Swanson,et al.  Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[328]  D. Cocchi,et al.  Growth hormone-releasing factor does not stimulate phosphoinositides breakdown in primary cultures of rat and human pituitary cells. , 1986, Acta endocrinologica.

[329]  R. Hammer,et al.  Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth , 1985, Nature.

[330]  D. Coy,et al.  Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. , 1985, Endocrinology.

[331]  F. Morel,et al.  Glucagon receptors along the nephron: [125I]glucagon binding in rat tubules , 1985, Pflügers Archiv.

[332]  L. Swanson,et al.  The distribution of growth‐hormone‐releasing factor (GRF) immunoreactivity in the central nervous system of the rat: An immunohistochemical study using antisera directed against rat hypothalamic GRF , 1985, The Journal of comparative neurology.

[333]  I. Mühlhauser,et al.  Incidence and Management of Severe Hypoglycemia in 434 Adults with Insulin-dependent Diabetes Mellitus , 1985, Diabetes Care.

[334]  R. Evans,et al.  Characterization of cDNA and genomic clones encoding the precursor to rat hypothalamic growth hormone-releasing factor , 1985, Nature.

[335]  W. Vale,et al.  Binding sites for growth hormone releasing factor on rat anterior pituitary cells , 1985, Nature.

[336]  G. Velicelebi,et al.  Specific binding of synthetic human pancreatic growth hormone releasing factor (1-40-OH) to bovine anterior pituitaries. , 1985, Biochemical and biophysical research communications.

[337]  N. Hoosein,et al.  Human glucagon‐like peptides 1 and 2 activate rat brain adenylate cyclase , 1984, FEBS letters.

[338]  N. Ueno,et al.  Synthesis and invitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor , 1984 .

[339]  N. Ling,et al.  Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[340]  N. Hoosein,et al.  Identification of glucagon receptors in rat brain. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[341]  R. Iyengar,et al.  Structural analysis of the hepatic glucagon receptor. Identification of a guanine nucleotide-sensitive hormone-binding region. , 1984, The Journal of biological chemistry.

[342]  A. Schally,et al.  Immunocytochemical localization of growth hormone-releasing factor in the rat hypothalamus. , 1984, Endocrinology.

[343]  N. Ling,et al.  Growth hormone-releasing factor regulates growth hormone mRNA in primary cultures of rat pituitary cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[344]  D. Coy,et al.  Super-active analogs of growth hormone-releasing factor (1-29)-amide. , 1984, Biochemical and biophysical research communications.

[345]  M. Thorner,et al.  Human pancreatic GRF stimulates phosphatidylinositol labeling in cultured anterior pituitary cells. , 1983, The American journal of physiology.

[346]  R. Evans,et al.  Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor , 1983, Nature.

[347]  R. Evans,et al.  Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor , 1983, Nature.

[348]  A. Kumar,et al.  Mammalian pancreatic preproglucagon contains three glucagon-related peptides. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[349]  W. Vale,et al.  Characterization of rat hypothalamic growth hormone-releasing factor , 1983, Nature.

[350]  G. Bell,et al.  Hamster preproglucagon contains the sequence of glucagon and two related peptides , 1983, Nature.

[351]  W. Vale,et al.  Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour , 1982, Nature.

[352]  N. Ling,et al.  Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. , 1982, Science.

[353]  K. Kovacs,et al.  Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. , 1982, The Journal of clinical investigation.

[354]  W. Creutzfeldt,et al.  Gastric inhibitory polypeptide. , 1980, Clinics in gastroenterology.

[355]  J. Gardner,et al.  Interaction of peptides related to secretin with hormone receptors on pancreatic acinar cells. , 1976, Gastroenterology.

[356]  L. Orci,et al.  Identification of glucagon-producing cells (A cells) in dog gastric mucosa , 1976, The Journal of cell biology.

[357]  W. Beamer,et al.  Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6. , 1976, The Journal of heredity.

[358]  J. Brown,et al.  Stimulation of insulin secretion by gastric inhibitory polypeptide in man. , 1973, The Journal of clinical endocrinology and metabolism.

[359]  L. Stimmler Glucagon and growth hormone. , 1973, British medical journal.

[360]  J. Isenberg,et al.  Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome. , 1972, Gastroenterology.

[361]  L. Birnbaumer,et al.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. 3. Binding of glucagon: method of assay and specificity. , 1971, The Journal of biological chemistry.

[362]  L. Birnbaumer,et al.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. , 1971, The Journal of biological chemistry.

[363]  R. Rosenblum Glucagon and the heart. , 1970, British medical journal.

[364]  R. Unger,et al.  Entero-insular axis. , 1969, Archives of internal medicine.

[365]  V. Marks,et al.  Interrelationship of Glucagon, Insulin and Glucose: The Insulinogenic Effect of Glucagon , 1966, Diabetes.

[366]  J. Beck,et al.  Stimulation of Release of Insulin by an Extract of Intestinal Mucosa , 1966, Diabetes.

[367]  V. Mutt,et al.  Structure of Porcine Secretin. I. Degradation with Trypsin and Thrombin. Sequence of the Tryptic Peptides. The C-Terminal Residue* , 1965 .

[368]  R. Unger,et al.  Localization of glucagon in the alpha cells in the pancreatic islet by immunofluorescent technics. , 1962, Diabetes.

[369]  O. Behrens,et al.  The Amino Acid Sequence of Glucagon , 1956, Diabetes.

[370]  A. Kenny Extractable glucagon of the human pancreas. , 1955, The Journal of clinical endocrinology and metabolism.

[371]  E. Sutherland The effect of the hyperglycemic factor of the pancreas and of the epinephrine on glycogenolys. , 1950, Omnia medica.

[372]  R. S. Allen,et al.  AQUEOUS EXTRACTS OF PANCREAS: IV. The Yield of Crude Insulin by Perfusion, Percolation and Simple Extraction , 1924 .

[373]  C. Kimball,et al.  AQUEOUS EXTRACTS OF PANCREAS III. SOME PRECIPITATION REACTIONS OF INSULIN , 1923 .

[374]  E. Starling,et al.  PRELIMINARY COMMUNICATION ON THE CAUSATION OF THE SO-CALLED "PERIPHERAL REFLEX SECRETION" OF THE PANCREAS. , 1902 .

[375]  Yazhou Li,et al.  Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. , 2003, The Journal of biological chemistry.

[376]  J. Sturis,et al.  Bedtime Administration of NN 2211 , a Long-Acting GLP-1 Derivative , Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes , 2002 .

[377]  G. Morel,et al.  Localization and regulation of a functional GHRH receptor in the rat renal medulla. , 2002, Endocrinology.

[378]  L. Plotnick,et al.  Three new mutations in the gene for the growth hormone (gh)-releasing hormone receptor in familial isolated gh deficiency type ib. , 2001, The Journal of clinical endocrinology and metabolism.

[379]  B. Yusta,et al.  Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. , 2001, Cancer research.

[380]  Ű. Langel,et al.  Different domains in the third intracellular loop of the GLP-1 receptor are responsible for Galpha(s) and Galpha(i)/Galpha(o) activation. , 2001, Biochimica et Biophysica Acta.

[381]  M. Schwartz,et al.  GLP-2alpha accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion. , 2001, Journal of pediatric surgery.

[382]  H. Holloway,et al.  Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent. , 2001, Endocrinology.

[383]  J. Zalvide,et al.  Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. , 2000, Endocrinology.

[384]  P. Godfrey,et al.  The rat growth hormone-releasing hormone receptor gene: structure, regulation, and generation of receptor isoforms with different signaling properties. , 1999, Endocrinology.

[385]  R. Pederson,et al.  Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin. , 1999, Endocrinology.

[386]  D. Bataille,et al.  Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes. , 1999, Endocrinology.

[387]  B. Yusta,et al.  Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[388]  Y. Kato,et al.  Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo. , 1999, Journal of pediatric surgery.

[389]  D. Bataille,et al.  Glicentin and Oxyntomodulin Modulate Both the Phosphoinositide and Cyclic Adenosine Monophosphate Signaling Pathways in Gastric Myocytes* *This work was supported by La Fondation pour la Recherche Médicale. , 1999, Endocrinology.

[390]  B. Göke,et al.  Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A. , 1999, Endocrinology.

[391]  B. Göke,et al.  Gene expression of the human glucagon-like peptide-1 receptor is regulated by Sp1 and Sp3. , 1999, Endocrinology.

[392]  E. Nillni,et al.  Posttranslational processing of progrowth hormone-releasing hormone. , 1999, Endocrinology.

[393]  M. Thorner,et al.  The mutant growth hormone-releasing hormone (GHRH) receptor of the little mouse does not bind GHRH. , 1999, Endocrinology.

[394]  D. Pipeleers,et al.  Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors. , 1998, Diabetes.

[395]  B. Göke,et al.  Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. , 1997, Proceedings of the Association of American Physicians.

[396]  安田浩一朗 HAMSTER GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR EXPRESSED IN PANCREATIC ISLETS AND CLONAL INSULINSECRETING CELLS: ITS STRUCTURE AND FUNCTIONAL PROPERTIES(膵ラ島およびインスリン分泌細胞株に発現するハムスターガストリックインヒビトリーポリペプチド受容体の構造と機能について) , 1997 .

[397]  B. Ozenberger,et al.  Investigation of growth hormone releasing hormone receptor structure and activity using yeast expression technologies. , 1997, Journal of receptor and signal transduction research.

[398]  R. Pederson,et al.  GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro. , 1997, Regulatory peptides.

[399]  D. Bataille Oxyntomodulin and Its Related Peptides , 1996 .

[400]  D. Bataille Preproglucagon and Its Processing , 1996 .

[401]  S. Chua,et al.  Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse , 1996, Nature Genetics.

[402]  C. Widmann,et al.  Structure and Function of the Glucagon-Like Peptide-1 Receptor , 1996 .

[403]  A. R. Friedman,et al.  Synthetic Analogues of Growth Hormone Releasing Factor (GHRF) with Improved Pharmaceutical Properties , 1996 .

[404]  S. Suhr,et al.  Growth hormone-releasing hormone: synthesis and signaling. , 1995, Recent progress in hormone research.

[405]  M. Thorner,et al.  Assignment of the human growth hormone-releasing hormone receptor gene (GHRHR) to 7p14 by in situ hybridization. , 1994, Genomics.

[406]  M. Thorner,et al.  Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. , 1993, Molecular endocrinology.

[407]  J. Holst,et al.  Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. , 1993, The Journal of clinical investigation.

[408]  I. Valverde,et al.  Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue. , 1993, Endocrinology.

[409]  M. Wheeler,et al.  The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37). , 1993, Endocrinology.

[410]  J. Habener,et al.  Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells. , 1992, Endocrinology.

[411]  J. Kraicer,et al.  Free intracellular Ca2+ concentration ([Ca2+]i) and growth hormone release from purified rat somatotrophs. I. GH-releasing factor-induced Ca2+ influx raises [Ca2+]i. , 1991, Endocrinology.

[412]  P. Lindström,et al.  The correlation between calcium outflow and growth hormone release in perifused rat somatotrophs. , 1990, Endocrinology.

[413]  N. Vamvakopoulos,et al.  Expression and localization of growth hormone-releasing hormone messenger ribonucleic acid in rat placenta: in vitro secretion and regulation of its peptide product. , 1990, Endocrinology.

[414]  W. Creutzfeldt,et al.  Gastrointestinal peptides and insulin secretion. , 1987, Diabetes/metabolism reviews.

[415]  G. Merriam,et al.  Growth hormone releasing hormone. , 1986, Annual review of physiology.

[416]  N. Ling,et al.  Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor. , 1984, Biochemical and biophysical research communications.

[417]  Graeme I. Bell,et al.  Exon duplication and divergence in the human preproglucagon gene , 1983, Nature.

[418]  T. Claus,et al.  Glucagon and Gluconeogenesis , 1983 .

[419]  W. Stalmans Glucagon and Liver Glycogen Metabolism , 1983 .

[420]  R. Goodman,et al.  Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[421]  L. Frohman,et al.  Ectopic production of growth hormone-releasing factor by carcinoid and pancreatic islet tumors associated with acromegaly. , 1981, Progress in clinical and biological research.

[422]  Eaton Rp Glucagon and Lipoprotein Regulation in Man , 1977 .

[423]  E. Starling,et al.  On the causation of the so-called ‘peripheral reflex secretion’ of the pancreas. (Preliminary communication.) , 1902, Proceedings of the Royal Society of London.